Finance & Accounting for Bioscience brings together CFOs, controllers and finance leaders from across the life sciences industry for two days of benchmarking and peer exchange in Boston. The agenda spans the issues shaping bioscience finance functions at every stage of growth, regulatory and accounting standards updates, capital allocation, commercialisation strategy, AI adoption and shifting geopolitical market dynamics. Sessions are CPE-accredited and led by industry thought leaders and government experts, with plenty of built-in time for networking.